Dr. Stefano Fanti's prominent career has been entirely devoted to Nuclear Medicine. For almost 3 decades he has been professionally linked to the PET Unit at the Polyclinic S. Orsola. His exhaustive management as Medical Director of that hospital service allowed an exponential growth of the same, both its facilities and equipment. As a result, in recent years the institution has performed more than 12,000 radiodiagnostic examinations, making it one of the most active in Europe.

Based on these results, the expert was selected to reorganize the functions of all the metropolitan centers with Nuclear Medicine tools in the region of Bologna, Italy. After this intensive professional task, he has held the position of Referent of the Maggiore Hospital Division. Also, still in charge of the PET Unit, Dr. Fanti has coordinated several grant applications for this center, receiving important funding from national institutions such as the Italian Ministry of Universities and the Regional Health Agency, Ministry of Universities.

On the other hand, this specialist has participated in many research projects on the clinical application of PET and PET/CT technologies in Oncology. In particular, he has investigated the approach to Lymphoma and Prostate Cancer. In turn, he has integrated the teams of many clinical trials with BCP requirements. In addition, he personally leads experimental analyses in the field of new PET tracers, including C-Choline, F-DOPA and Ga-DOTA-NOC, among others.

Also, Dr. Fanti is a collaborator of the International Atomic Energy Organization (IAEA), participating in initiatives such as the consensus for the introduction of radiopharmaceuticals for clinical use and other advisory missions. He is also the author of more than 600 articles published in international journals and is a reviewer for The Lancet Oncology, The American Journal of Cancer, BMC Cancer, among others.

• Director of the Specialized School of Nuclear Medicine of the University of Bologna, Italy
• Director of the Division of Nuclear Medicine and of the PET Unit of Polyclinic S. Orsola
• Referent of the Division of Nuclear Medicine, Maggiore Hospital
• Associate Editor of Clinical and Translational Imaging, the European Journal of Nuclear Medicine and the Spanish Journal of Nuclear Medicine 
• Reviewer for The Lancet Oncology, The American Journal of Cancer, BMC Cancer, European Urology, The European Journal of Hematology, Clinical Cancer Research, and other international journals
• Advisor to the International Atomic Energy Organization (IAEA)
• Member of:
  
  • European Association of Nuclear Medicine